Pharmabiz

European Commission approves Merck’s Keytruda as part of a treatment regimen for adults with resectable LA-HNSCC expressing PD-L1

European Commission approves Merck’s Keytruda as part of a treatment regimen for adults with resectable LA-HNSCC expressing PD-L1: Rahway, New Jersey Thursday, October 30, 2025, ...
Pharmabiz

EU GMP certification helps Indian drug manufacturing plants to align with global quality standards: Arpit Bhatia

Shardul Nautiyal, Mumbai Thursday, October 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

IPA Kerala to host workshop on GMP compliance & RPTUAS incentives in Kochi on Oct-31

IPA Kerala to host workshop on GMP compliance & RPTUAS incentives in Kochi on Oct-31: Peethaambaran Kunnathoor, Chennai Thursday, October 30, 2025, 08:00 Hrs [IST] The Indian Phar ...
Pharmabiz

GMP endorses excellence and integrity in pharma production: Kaushik Desai

GMP is not merely a set of guidelines, but is the foundation on which public health and the integrity of the pharmaceutical industry stand, said Kaushik Desai, Executive Committee Member, Industry ...
Pharmabiz

Health ministry issues draft rules to debar applicants submitting misleading or forged information

Health ministry issues draft rules to debar applicants submitting misleading or forged information: Gireesh Babu, New Delhi Thursday, October 30, 2025, 08:00 Hrs [IST] The Union m ...
Pharmabiz

EMA grants Orphan Drug Designation to GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 to treat pulmonary neuroendocrine carcinoma

EMA grants Orphan Drug Designation to GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 to treat pulmonary neuroendocrine carcinoma: London, UK Wednesday, October 29, 2025 ...
Pharmabiz

Ajinomoto Bio-Pharma & Olon S.p.A. form strategic partnership to advance large-scale peptide and protein manufacturing

Ajinomoto Bio-Pharma & Olon S.p.A. form strategic partnership to advance large-scale peptide and protein manufacturing: Tokyo, Japan Wednesday, October 29, 2025, 17:00 Hrs [IST] A ...
Pharmabiz

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial: New Hope, Pennsylvania Wednesday, October 29, 2025, 18:00 Hrs [IST] O ...
Pharmabiz

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes: Our Bureau, Mumbai Wednesday, October 29, 2025, 16:15 Hrs [IST] Sahajanand Medical Technologies (SMT), a medi ...
Pharmabiz

First UK patient with multiple sclerosis treated with CAR T cell therapy

First UK patient with multiple sclerosis treated with CAR T cell therapy: United Kingdom Wednesday, October 29, 2025, 15:00 Hrs [IST] A patient with multiple sclerosis has become ...
Pharmabiz

Metropolis Healthcare study reveals 46% of tested individuals show vitamin D deficiency across India

Metropolis Healthcare study reveals 46% of tested individuals show vitamin D deficiency across India: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:30 Hrs [IST] Metropolis ...
Pharmabiz

Philips introduces industry-first cath lab integration; paving the way for CT-guided PCI

Philips introduces industry-first cath lab integration; paving the way for CT-guided PCI: San Francisco Wednesday, October 29, 2025, 14:00 Hrs [IST] Royal Philips, a global leader ...